Low-income JA Patients Face Double Hurdle to Care A new study shows low-income juvenile arthritis patients less likely referred to specialty care for proper diagnosis and treatment. 7/12/11
Gaining Ground in Juvenile Arthritis Research A scientist makes new discoveries in the field of juvenile arthritis research.
New Drug Approved for Severe Juvenile Arthritis Actemra, already approved for adults with rheumatoid arthritis, got FDA approval to treat kids with a rare form of the disease 4/20/11
Researcher Makes Major JA Discoveries Edward Behrens, a pediatric rheumatologist is unraveling the mysteries of a life-threatening syndrome that strikes children with arthritis 9/23/10
Age, Gender Influence Dangerous Eye Complication in Children Study identifies new factors that put kids with juvenile arthritis at risk for uveitis 6/23/10
Live Vaccines May be Safe for Kids with Arthritis A small study found the chickenpox vaccine was safe and effective in children with JA 7/21/10
No Link to Anti-TNF Drugs and Cancer in JA New study finds this class of biologics doesn’t raise cancer risk in juvenile arthritis 11/19/10
Kids in Remission Can Come Off Meds Staying on methotrexate doesn't alter relapse risk 11/18/09
Childhood Arthritis Deaths Drop Better treatments show increased survival 02/05/10
Fear of Layoff Affects Children's Arthritis Care Parents worry taking time off for doctor appointments puts their jobs at risk. 3/24/10
The High Price of Arthritis: The Personal and Financial Toll Think your aches and pains are expensive? You’re right. The sky-rocketing costs of joint diseases are taking a heavy personal and national financial toll.